Department of Hematology, Cancer Hospital of the University of Chinese Academy of Sciences (Zhejiang Cancer Hospital), Hangzhou 310022, China.
Institute of Cancer and Basic Medicine (IBMC), Chinese Academy of Sciences, Hangzhou 310000, China.
Curr Oncol. 2022 Feb 15;29(2):1136-1149. doi: 10.3390/curroncol29020097.
The objective of this paper is to identify the prognostic risk factors of secondary adult hemophagocytic syndrome (HLH) in hospitalized patients and establish a simple and convenient prognostic scoring system.
We reviewed 162 adult patients secondary with HLH treated in Zhejiang Cancer Hospital and the First Affiliated Hospital of Medical College of Zhejiang University from January 2014 to December 2018 were enrolled to form the test group; from January 2019 to February 2021, 162 adult patients in the hospitals constituted the validation group. The HLH prognosis scoring system was constructed according to the risk factors, and the patients were divided into three risk groups: low risk, medium risk, and high risk. The scoring system was verified by Kaplan-Meier method and log rank test survival analysis. The discrimination ability was evaluated according to the receiver operating characteristic (ROC) curve.
Univariate and multivariate analysis showed that the independent risk factors for the prognosis of HLH were male sex, activated partial prothrombin time (APTT) greater than 36 s, lactate dehydrogenase (LDH) greater than 1000 U/L, and C-reactive protein (CRP) greater than 100 mg/L. The area under the ROC curve was 0.754 (95% Cl: 0.678-0.829). The patients were divided into a low-risk group (0-1), a medium-risk group (2-4), and a high-risk group (5-6). The 5-year overall survival (OS) rate were 87.5%, 41.8% and 12.8%, respectively ( < 0.001). The area under ROC curve was 0.736 (95% Cl: 0.660-0.813) in the validation group, and the 2-year OS of patients in low-risk, medium-risk and high-risk groups were 88.0%, 45.1% and 16.7%, respectively ( < 0.001).
The new prognostic scoring system can accurately predict the prognosis of secondary adult HLH and can further provide basis for the accurate treatment of secondary adult HLH.
本文旨在确定住院患者继发成人噬血细胞综合征(HLH)的预后危险因素,并建立一个简单方便的预后评分系统。
我们回顾性分析了 2014 年 1 月至 2018 年 12 月在浙江省肿瘤医院和浙江大学医学院附属第一医院治疗的 162 例继发 HLH 的成年患者,组成试验组;2019 年 1 月至 2021 年 2 月,两所医院的 162 例成年患者组成验证组。根据危险因素构建 HLH 预后评分系统,并将患者分为低危、中危和高危 3 个风险组。采用 Kaplan-Meier 法和对数秩检验生存分析对评分系统进行验证,根据受试者工作特征(ROC)曲线评估其判别能力。
单因素和多因素分析显示,男性、活化部分凝血活酶时间(APTT)大于 36 s、乳酸脱氢酶(LDH)大于 1000 U/L、C 反应蛋白(CRP)大于 100 mg/L 是 HLH 预后的独立危险因素。ROC 曲线下面积为 0.754(95%Cl:0.678-0.829)。患者被分为低危组(0-1)、中危组(2-4)和高危组(5-6)。5 年总生存率(OS)分别为 87.5%、41.8%和 12.8%(<0.001)。验证组 ROC 曲线下面积为 0.736(95%Cl:0.660-0.813),低危、中危和高危组患者的 2 年 OS 分别为 88.0%、45.1%和 16.7%(<0.001)。
新的预后评分系统能准确预测继发成人 HLH 的预后,可为准确治疗继发成人 HLH 提供依据。